Open AccessP‐090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
HemaspherePeer ReviewedF. GALACTÉROS +62022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support